Digital Biomarkers Market on Track for Strong Growth, Estimated to Grow at 26% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Digital Biomarkers Market Through 2025?
Over recent years, the digital biomarkers market has experienced substantial growth. Projections indicate an increase from $3.92 billion in 2024 to $4.96 billion in 2025, with a compound annual growth rate (CAGR) of 26.3%. This impressive historical growth trend can be linked to factors such as the expansion of mobile health applications, early implementation in clinical trials, increasing incidence of chronic diseases, heightened consumer interest in fitness and well-being, and the progressive digitalization of healthcare.

What's the Projected Size of the Global Digital Biomarkers Market by 2029?
The market size for digital biomarkers is projected to experience significant expansion in the forthcoming years, reaching a value of $12.52 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 26.1%. Factors contributing to this growth during the forecast period include the increasing embrace by healthcare providers, the rising incidence of chronic illnesses, heightened consumer awareness, and a growing interest in monitoring fitness and lifestyle factors among consumers. Key trends for the forecasted period consist of advancements in wearable tech, the incorporation of artificial intelligence, strategic collaborations and partnerships, growth in emerging markets, and integration with electronic health records.

View the full report here:
https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Top Growth Drivers in the Digital Biomarkers Industry: What's Accelerating the Market?
Anticipations for the growth of the digital biomarkers market are largely driven by the increasing prevalence of chronic diseases. These conditions, which usually develop gradually and persist over extended periods, often lifelong, include age-related health problems such as osteoarthritis, Alzheimer's disease, and heart disease. The likelihood of developing such diseases is amplified by factors like frequent consumption of processed foods and lack of physical exercise. Digital biomarkers play a crucial role in chronic disease management, providing real-time monitoring of health metrics and disease progression which facilitates personalized, timely interventions. For instance, the Centers for Disease Control and Prevention (CDC.gov), a US government entity, reported in May 2023 that there was an increase in deaths due to heart disease and cancer from 6,05,213 in 2021 to 6,95,547 in 2022. In view of this, the escalating prevalence of chronic diseases is set to stimulate the expansion of the digital biomarker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

What Trends Will Shape the Digital Biomarkers Market Through 2029 and Beyond?
Prominent businesses in the digital biomarker sector are employing a strategic alliance method to broaden their customer base and increase their service range. A strategic alliance often pertains to a combined effort by multiple organizations aimed at pooling their resources, skills, and endeavors to satisfy shared ambitions or targets. For instance, ProofPilot, an American clinical trial automation supplier, joined forces with Eli Lilly and Company, an American pharmaceutical firm, in September 2023. The partnership's objective is to incorporate Lilly's innovative, pending-patent sensor cloud technology, Magnol.AI, into ProofPilot's tech portfolio. Magnol.AI is a state-of-the-art platform that handles high-frequency sensor data with remarkable security and simplicity. The collaboration seeks to improve the implementation of top-tier digital health research and speed up the process of non-competitive biomedical studies. The merging of these systems allows investigators to apply real-time data science capabilities and glean profound understandings from sensor data, matching clinician and patient-reported results to push forward digital health and biomarker research.

What Are the Main Segments in the Digital Biomarkers Market?
The digital biomarkersmarket covered in this report is segmented -

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types
2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices
3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications
4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:
1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors
2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps
3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors
4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19397&type=smp

Which Top Companies are Driving Growth in the Digital Biomarkers Market?
Major companies operating in the digital biomarkers market are Pfizer Inc., Bayer AG, F Hoffmann-La Roche Ltd., Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc., Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc., AliveCor Inc., Empatica Inc., ActiGraph LLC, VivoSense Inc., BioSensics LLC, Koneksa Health Inc., ATCOR Medical Pty Ltd., Brainomix Limited

Which Regions Will Dominate the Digital Biomarkers Market Through 2029?
North America was the largest region in the digital biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19397

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.